Burning Rock Biotech BNR Income Statement (2019-2026)

NASDAQ BNR
$10.00 -0.44 (-4.21%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Burning Rock Biotech Quarterly Income Statement

Periods 29 quarters
Latest Mar 2026

Burning Rock Biotech reported revenue of $15.65M and net income of -$2.53M for the quarter ended Mar 2026, down 14.7% year over year. This income statement covers 29 quarters of results from Mar 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
19.71M19.65M23.12M21.38M19.53M21.74M20.62M20.75M20.17M17.48M17.05M17.40M18.65M18.33M17.27M18.34M20.74M18.49M18.06M15.65M
Cost of RevenueCost of Rev
5.74M5.43M6.58M7.56M7.20M6.47M5.94M6.37M6.32M5.71M6.05M5.53M5.52M5.24M5.01M4.92M5.65M4.60M3.97M4.34M
Gross Profit
13.97M14.21M16.54M13.82M12.33M15.27M14.68M14.38M13.85M11.78M11.00M11.87M13.13M13.09M12.25M13.42M15.09M13.88M14.10M11.31M
Operating items
Research & DevelopmentR&D
-16.74M-10.81M-17.69M-18.85M-13.75M-15.38M-14.62M-13.75M-13.21M-11.47M-10.30M-9.14M-8.94M-7.00M-7.15M-5.57M-6.95M-5.83M-4.99M-4.00M
Selling, General & AdministrativeSG&A
-17.99M-18.05M-22.21M-22.36M-22.44M-20.18M-19.24M-18.64M-9.59M-16.27M-17.12M-13.67M-12.77M-4.68M-5.11M-4.31M-4.39M-4.45M-4.53M-4.07M
Other Operating ExpensesOther Opex
-10.54M-11.90M-16.20M-14.06M-15.77M-12.69M-12.35M-9.47M-10.11M-8.54M-7.01M-6.49M-6.76M-6.90M-11.21M-5.62M-5.31M-5.84M-6.30M-5.95M
Operating ExpensesOpex
-45.27M-40.76M-56.10M-55.28M-51.97M-48.25M-46.21M-41.82M-32.57M-36.28M-34.43M-29.30M-28.44M-18.59M-23.48M-15.52M-16.70M-16.15M-15.82M-14.04M
Operating IncomeOp. Inc
-31.29M-26.55M-39.56M-41.47M-39.63M-32.98M-31.53M-27.44M-18.72M-24.51M-23.43M-17.43M-15.30M-5.50M-11.22M-2.09M-1.60M-2.27M-1.72M-2.73M
EBIT
-31.29M-26.55M-39.56M-41.42M-39.63M-32.98M-31.53M-27.55M-19.38M-24.51M-23.43M-17.43M-15.36M-5.50M-11.22M-2.09M-1.59M-2.25M-1.72M-2.72M
Non-operating items
Non Operating Interest Expenses
-0.09M-0.06M-0.01M-0.00M-0.00M-0.00M
Interest & Investment IncomeInt & Inv Inc
0.30M1.33M2.49M1.70M
Other Non Operating IncomeOther Non Op Inc.
-0.09M0.00M-0.12M-0.12M0.09M0.19M0.05M0.09M-0.02M0.06M0.02M0.06M-0.01M-0.58M0.60M-0.09M-0.08M0.00M-0.29M0.04M
Net income details
EBT
-31.29M-26.39M-39.59M-41.23M-39.12M-32.54M-31.07M-26.91M-18.04M-23.92M-22.70M-16.81M-14.84M-5.07M-10.41M-1.83M-1.32M-2.33M-2.07M-2.50M
Tax ProvisionsTaxes
-0.25M-0.07M0.18M-0.01M-0.28M-0.06M-0.06M-0.06M-0.15M-0.03M-0.03M-0.03M-0.73M-0.03M-0.03M-0.03M-0.12M-0.03M
Profit After TaxPAT
-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.14M-1.86M-1.35M-2.35M-2.20M-2.53M
Income from Non-Controlling InterestsInc. Minority
12.91M8.28M9.50M12.63M11.70M11.38M12.89M11.43M5.40M10.15M9.91M9.70M9.41M1.41M1.12M0.63M
Income from Continuing OperationsIncome (Continuing)
-31.04M-26.33M-39.77M-41.18M-39.11M-32.54M-30.80M-26.96M-18.61M-23.86M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M-2.46M
Consolidated Net IncomeConsol Net Inc.
-31.04M-26.33M-39.77M-41.18M-39.11M-32.54M-30.80M-26.96M-18.61M-23.86M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M-2.46M
Income towards Parent CompanyParent Net Inc
-31.04M-26.33M-73.81M-41.18M-39.11M-32.54M-112.02M-26.96M-18.61M-23.86M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M-2.46M
Preferred Dividend PaymentsPref Dividends
-10.12M
Net Income towards Common StockholdersNet Income
-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.32M-1.86M-1.35M-2.35M-2.20M-2.53M
Additional items
EPS (Basic)
-95.37-79.99-4.54-4.75-118.32-98.38-3.02-2.60-1.74-2.31-2.69-1.98-1.75-0.60-1.10-0.18-0.13-0.23-0.25-0.28
EPS (Diluted)
-4.60-3.85-4.54-4.75-4.50-3.75-3.02-2.60-1.74-2.31-2.23-1.64-1.45-0.50-1.10-0.18-0.13-0.23-0.21-0.24
Shares Outstanding
0.33M0.33M8.69M8.69M0.33M0.33M10.39M10.39M10.39M10.39M8.51M8.51M8.51M8.51M10.29M10.29M10.29M10.29M8.90M8.90M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
6.86M6.86M8.69M8.69M8.69M8.69M10.39M10.39M10.39M10.39M10.24M10.24M10.24M10.24M10.29M10.29M10.29M10.29M10.63M10.63M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.33M10.51M0.33M10.26M10.24M10.76M10.52M
EBITDA
-31.29M-26.55M-39.56M-41.42M-39.63M-32.98M-31.53M-27.55M-19.38M-24.51M-23.43M-17.43M-15.36M-5.50M-11.22M-2.09M-1.59M-2.25M-1.72M-2.72M
Interest ExpensesInt Expense
-0.09M-0.06M-0.01M-0.00M-0.00M-0.00M
Tax Rate
0.81%0.25%-0.46%0.03%0.89%0.23%0.34%0.26%0.67%0.15%0.18%0.57%6.99%1.69%2.58%1.29%6.03%1.36%